Cosentyx (secukinumab) is a biologic medication used to treat various inflammatory conditions, including pediatric psoriasis. The recommended dosage for children is based on their body weight, with a maximum dose of 150 mg per injection [3].

According to the Cosentyx website, the recommended starting dose for pediatric psoriasis patients is 75 mg for children weighing between 20 kg and 50 kg, and 150 mg for children weighing more than 50 kg [2]. After the initial dose, subsequent doses are given at four-week intervals. The website also notes that the safety and efficacy of Cosentyx have not been established in children under the age of 6 years [2].

The Drug Patent Watch website provides additional information on the dosing of Cosentyx for pediatric psoriasis. It notes that the recommended dose for children weighing between 10 kg and 20 kg is 37.5 mg, and the recommended dose for children weighing between 20 kg and 50 kg is 75 mg [1]. The website also notes that the dosing regimen for pediatric psoriasis is the same as that for adult psoriasis patients [1].

In summary, the recommended dosages for Cosentyx in children with psoriasis depend on their body weight, with a maximum dose of 150 mg per injection. The starting dose is 75 mg for children weighing between 20 kg and 50 kg, and 150 mg for children weighing more than 50 kg. The safety and efficacy of Cosentyx have not been established in children under the age of 6 years. It is important to consult with a healthcare provider to determine the appropriate dosage for a specific child.

Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX
[2] https://www.cosentyx.com/pediatric-psoriasis
[3] https://info.cosentyx.com/pediatric-psoriasis/efficacy-safety-dosing